NCT00499473 2016-02-29Sunitinib in Treating Patients With Recurrent Malignant GliomasNational Cancer Institute (NCI)Phase 2 Completed31 enrolled 6 charts
NCT01462695 2015-08-27Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or EpendymomaNational Cancer Institute (NCI)Phase 2 Completed30 enrolled 8 charts